A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma
Technology in Cancer Research & Treatment · 2026-04 · 25
DOI: 10.1177/15330338261444986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 18.04.2026. Verfasst von Xiang-Ling Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Nomograms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Introduction
We introduce a standardized necrosis rate—percent reduction in enhancing tumor diameter normalized by baseline tumor diameter—with a threshold of ≥30%. This endpoint is derived from the mRECIST partial response criteria but is normalized to mitigate tumor size-dependent bias. A clinical–radiomics model was developed to assess necrosis in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE).
Methods
Retrospectively, 95 HCC patients undergoing TACE were included. Radiomics features were selected via LASSO regression, and clinical variables via logistic regression. Separate radiomics and clinical models were developed, and a combined model was constructed using multivariable logistic regression. The cohort was randomly split into training (70%) and validation (30%) sets, with all preprocessing, feature selection, and model training confined to the training set to prevent data leakage. Model performance was evaluated using discrimination (AUC), calibration, clinical utility (decision curve analysis), and a nomogram.
Results
From 1,316 extracted radiomics features, six were retained for Rad-score calculation. Key clinical predictors included hepatitis group, standardized viable tumor ratio, and vascular invasion. The integrated model achieved AUCs of 0.865 (95% CI: 0.768–0.961) in training and 0.853 (95% CI: 0.716–0.990) in validation (n=29), outperforming the clinical model (AUCs: 0.808 (95% CI: 0.695-0.922) and 0.666 (95% CI: 0.465-0.866), respectively). Decision curve analysis and calibration plots confirmed the combined model’s superior performance.
Conclusion
The radiomics–clinical nomogram, based on a standardized necrosis rate, may enable early prediction of TACE response, offering potential insights for therapeutic decision-making, risk stratification, and liver transplantation management. External validation is warranted before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, China.
- Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control (Guangxi Zhuang Autonomous Region Academy of Preventive Medicine), Nan…
- Department of Otolaryngology-Head and Neck Surgery, Tongren Second People's Hospital, Tongren, Guizhou, China.
- Department of Radiology, The Second People's Hospital of China Three Gorges University, Yichang, Hubei, China.
ORCID-Profile: Xiang-Ling Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Wu, X. L., Duan, B. Z., Jiang, Z. H., Zeng, S. S., Lin, G. C., & Fang, Z. L. (2026). A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261444986
Vancouver
Wu XL, Duan BZ, Jiang ZH, Zeng SS, Lin GC, Fang ZL. A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261444986
BibTeX
@article{Wu2026,
author = {Wu, Xiang-Ling and Duan, Bing-Zhi and Jiang, Zhi-Hua and Zeng, Shan-Shan and Lin, Guo-Cheng and Fang, Zhong-Liao},
title = {A Clinical–Radiomics Nomogram Predicts Early Tumor Necrosis After Transarterial Chemoembolization for Hepatocellular Carcinoma},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
volume = {25},
doi = {10.1177/15330338261444986}
}
EUVIMED